Table of Content

1 Nuclear Medicine/Radiopharmaceutic Market Overview
1.1 Nuclear Medicine/Radiopharmaceutic Product Scope
1.2 Nuclear Medicine/Radiopharmaceutic Segment by Type
1.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2016 & 2021 & 2027)
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Other
1.3 Nuclear Medicine/Radiopharmaceutic Segment by Application
1.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Nuclear Medicine/Radiopharmaceutic Market Estimates and Forecasts (2016-2027)
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Nuclear Medicine/Radiopharmaceutic Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Nuclear Medicine/Radiopharmaceutic Price Trends (2016-2027)

2 Nuclear Medicine/Radiopharmaceutic Estimates and Forecasts by Region
2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2016-2021)
2.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2016-2021)
2.3 Global Nuclear Medicine/Radiopharmaceutic Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Nuclear Medicine/Radiopharmaceutic Estimates and Projections (2016-2027)
2.4.2 Europe Nuclear Medicine/Radiopharmaceutic Estimates and Projections (2016-2027)
2.4.3 China Nuclear Medicine/Radiopharmaceutic Estimates and Projections (2016-2027)
2.4.4 Japan Nuclear Medicine/Radiopharmaceutic Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Nuclear Medicine/Radiopharmaceutic Estimates and Projections (2016-2027)
2.4.6 India Nuclear Medicine/Radiopharmaceutic Estimates and Projections (2016-2027)

3 Global Nuclear Medicine/Radiopharmaceutic Competition Landscape by Players
3.1 Global Top Nuclear Medicine/Radiopharmaceutic Players by Sales (2016-2021)
3.2 Global Top Nuclear Medicine/Radiopharmaceutic Players by Revenue (2016-2021)
3.3 Global Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear Medicine/Radiopharmaceutic as of 2020)
3.4 Global Nuclear Medicine/Radiopharmaceutic Average Price by Company (2016-2021)
3.5 Manufacturers Nuclear Medicine/Radiopharmaceutic Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Nuclear Medicine/Radiopharmaceutic Market Size by Type
4.1 Global Nuclear Medicine/Radiopharmaceutic Historic Market Review by Type (2016-2021)
4.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2021)
4.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2016-2021)
4.1.3 Global Nuclear Medicine/Radiopharmaceutic Price by Type (2016-2021)
4.2 Global Nuclear Medicine/Radiopharmaceutic Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2022-2027)
4.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2022-2027)
4.2.3 Global Nuclear Medicine/Radiopharmaceutic Price Forecast by Type (2022-2027)

5 Global Nuclear Medicine/Radiopharmaceutic Market Size by Application
5.1 Global Nuclear Medicine/Radiopharmaceutic Historic Market Review by Application (2016-2021)
5.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2021)
5.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2016-2021)
5.1.3 Global Nuclear Medicine/Radiopharmaceutic Price by Application (2016-2021)
5.2 Global Nuclear Medicine/Radiopharmaceutic Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2022-2027)
5.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Application (2022-2027)
5.2.3 Global Nuclear Medicine/Radiopharmaceutic Price Forecast by Application (2022-2027)

6 North America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures
6.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Company
6.1.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2021)
6.1.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Company (2016-2021)
6.2 North America Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type
6.2.1 North America Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type (2016-2021)
6.2.2 North America Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type (2022-2027)
6.3 North America Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Application
6.3.1 North America Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Application (2016-2021)
6.3.2 North America Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Application (2022-2027)

7 Europe Nuclear Medicine/Radiopharmaceutic Market Facts & Figures
7.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Company
7.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2021)
7.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Company (2016-2021)
7.2 Europe Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type
7.2.1 Europe Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type (2016-2021)
7.2.2 Europe Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type (2022-2027)
7.3 Europe Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Application
7.3.1 Europe 129 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 129 Sales Breakdown by Application (2022-2027)

8 China Nuclear Medicine/Radiopharmaceutic Market Facts & Figures
8.1 China Nuclear Medicine/Radiopharmaceutic Sales by Company
8.1.1 China Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2021)
8.1.2 China Nuclear Medicine/Radiopharmaceutic Revenue by Company (2016-2021)
8.2 China Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type
8.2.1 China Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type (2016-2021)
8.2.2 China Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type (2022-2027)
8.3 China Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Application
8.3.1 China 157 Sales Breakdown by Application (2016-2021)
8.3.2 China 157 Sales Breakdown by Application (2022-2027)

9 Japan Nuclear Medicine/Radiopharmaceutic Market Facts & Figures
9.1 Japan Nuclear Medicine/Radiopharmaceutic Sales by Company
9.1.1 Japan Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2021)
9.1.2 Japan Nuclear Medicine/Radiopharmaceutic Revenue by Company (2016-2021)
9.2 Japan Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type
9.2.1 Japan Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type (2016-2021)
9.2.2 Japan Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type (2022-2027)
9.3 Japan Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Nuclear Medicine/Radiopharmaceutic Market Facts & Figures
10.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales by Company
10.1.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2021)
10.1.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue by Company (2016-2021)
10.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type
10.2.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Application
10.3.1 Southeast Asia Kiloton Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kiloton Sales Breakdown by Application (2022-2027)

11 India Nuclear Medicine/Radiopharmaceutic Market Facts & Figures
11.1 India Nuclear Medicine/Radiopharmaceutic Sales by Company
11.1.1 India Nuclear Medicine/Radiopharmaceutic Sales by Company (2016-2021)
11.1.2 India Nuclear Medicine/Radiopharmaceutic Revenue by Company (2016-2021)
11.2 India Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type
11.2.1 India Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type (2016-2021)
11.2.2 India Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Type (2022-2027)
11.3 India Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Application
11.3.1 India Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Application (2016-2021)
11.3.2 India Nuclear Medicine/Radiopharmaceutic Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Nuclear Medicine/Radiopharmaceutic Business
12.1 GE Healthcare
12.1.1 GE Healthcare Corporation Information
12.1.2 GE Healthcare Business Overview
12.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
12.1.5 GE Healthcare Recent Development
12.2 Bracco Imaging
12.2.1 Bracco Imaging Corporation Information
12.2.2 Bracco Imaging Business Overview
12.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
12.2.5 Bracco Imaging Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Business Overview
12.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Lantheus Medical Imaging
12.4.1 Lantheus Medical Imaging Corporation Information
12.4.2 Lantheus Medical Imaging Business Overview
12.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
12.4.5 Lantheus Medical Imaging Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Business Overview
12.5.3 Bayer Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Products Offered
12.5.5 Bayer Recent Development
12.6 Jubilant Pharma
12.6.1 Jubilant Pharma Corporation Information
12.6.2 Jubilant Pharma Business Overview
12.6.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Products Offered
12.6.5 Jubilant Pharma Recent Development
12.7 Nordion
12.7.1 Nordion Corporation Information
12.7.2 Nordion Business Overview
12.7.3 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Nordion Nuclear Medicine/Radiopharmaceutic Products Offered
12.7.5 Nordion Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Corporation Information
12.8.2 Eli Lilly Business Overview
12.8.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Products Offered
12.8.5 Eli Lilly Recent Development
12.9 SIEMENS
12.9.1 SIEMENS Corporation Information
12.9.2 SIEMENS Business Overview
12.9.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Products Offered
12.9.5 SIEMENS Recent Development
12.10 China Isotope & Radiation
12.10.1 China Isotope & Radiation Corporation Information
12.10.2 China Isotope & Radiation Business Overview
12.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Products Offered
12.10.5 China Isotope & Radiation Recent Development
12.11 Yantai Dongcheng Biochemicals
12.11.1 Yantai Dongcheng Biochemicals Corporation Information
12.11.2 Yantai Dongcheng Biochemicals Business Overview
12.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Products Offered
12.11.5 Yantai Dongcheng Biochemicals Recent Development

13 Nuclear Medicine/Radiopharmaceutic Manufacturing Cost Analysis
13.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
13.4 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Nuclear Medicine/Radiopharmaceutic Distributors List
14.3 Nuclear Medicine/Radiopharmaceutic Customers

15 Market Dynamics
15.1 Nuclear Medicine/Radiopharmaceutic Market Trends
15.2 Nuclear Medicine/Radiopharmaceutic Drivers
15.3 Nuclear Medicine/Radiopharmaceutic Market Challenges
15.4 Nuclear Medicine/Radiopharmaceutic Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Nuclear Medicine/Radiopharmaceutic Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Nuclear Medicine/Radiopharmaceutic Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Nuclear Medicine/Radiopharmaceutic Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Region (2016-2021)
Table 5. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2016-2021)
Table 6. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Region (2016-2021)
Table 8. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Forecast by Region (2022-2027)
Table 9. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Nuclear Medicine/Radiopharmaceutic Revenue Share Forecast by Region (2022-2027)
Table 12. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) of Key Companies (2016-2021)
Table 13. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Company (2016-2021)
Table 14. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Company (2016-2021)
Table 16. Global Nuclear Medicine/Radiopharmaceutic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceutic as of 2020)
Table 17. Global Nuclear Medicine/Radiopharmaceutic Average Price (US$/Ton) of Key Company (2016-2021)
Table 18. Manufacturers Nuclear Medicine/Radiopharmaceutic Manufacturing Sites and Area Served
Table 19. Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2016-2021)
Table 22. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2016-2021)
Table 23. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Nuclear Medicine/Radiopharmaceutic Price (US$/Ton) by Type (2016-2021)
Table 25. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2022-2027)
Table 26. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2022-2027)
Table 28. Global Nuclear Medicine/Radiopharmaceutic Price (US$/Ton) by Type (2022-2027)
Table 29. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2016-2021)
Table 30. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2016-2021)
Table 31. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Nuclear Medicine/Radiopharmaceutic Price (US$/Ton) by Application (2016-2021)
Table 33. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2022-2027)
Table 34. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2022-2027)
Table 35. Global Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Application (2022-2027)
Table 37. Global Nuclear Medicine/Radiopharmaceutic Price (US$/Ton) by Application (2022-2027)
Table 38. North America Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Company (2016-2021)
Table 39. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2021)
Table 40. North America Nuclear Medicine/Radiopharmaceutic Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Company (2016-2021)
Table 42. North America Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2021) & (Kiloton)
Table 43. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2021)
Table 44. North America Nuclear Medicine/Radiopharmaceutic Sales by Type (2022-2027) & (Kiloton)
Table 45. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2022-2027)
Table 46. North America Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2021) & (Kiloton)
Table 47. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2021)
Table 48. North America Nuclear Medicine/Radiopharmaceutic Sales by Application (2022-2027) & (Kiloton)
Table 49. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2022-2027)
Table 50. Europe Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Company (2016-2021)
Table 51. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2021)
Table 52. Europe Nuclear Medicine/Radiopharmaceutic Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Company (2016-2021)
Table 54. Europe Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2021) & (Kiloton)
Table 55. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2021)
Table 56. Europe Nuclear Medicine/Radiopharmaceutic Sales by Type (2022-2027) & (Kiloton)
Table 57. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2022-2027)
Table 58. Europe Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2021) & (Kiloton)
Table 59. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2021)
Table 60. Europe Nuclear Medicine/Radiopharmaceutic Sales by Application (2022-2027) & (Kiloton)
Table 61. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2022-2027)
Table 62. China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Company (2016-2021)
Table 63. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2021)
Table 64. China Nuclear Medicine/Radiopharmaceutic Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Company (2016-2021)
Table 66. China Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2021) & (Kiloton)
Table 67. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2021)
Table 68. China Nuclear Medicine/Radiopharmaceutic Sales by Type (2022-2027) & (Kiloton)
Table 69. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2022-2027)
Table 70. China Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2021) & (Kiloton)
Table 71. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2021)
Table 72. China Nuclear Medicine/Radiopharmaceutic Sales by Application (2022-2027) & (Kiloton)
Table 73. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2022-2027)
Table 74. Japan Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Company (2016-2021)
Table 75. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2021)
Table 76. Japan Nuclear Medicine/Radiopharmaceutic Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Company (2016-2021)
Table 78. Japan Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2021) & (Kiloton)
Table 79. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2021)
Table 80. Japan Nuclear Medicine/Radiopharmaceutic Sales by Type (2022-2027) & (Kiloton)
Table 81. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2022-2027)
Table 82. Japan Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2021) & (Kiloton)
Table 83. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2021)
Table 84. Japan Nuclear Medicine/Radiopharmaceutic Sales by Application (2022-2027) & (Kiloton)
Table 85. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Company (2016-2021)
Table 87. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2021) & (Kiloton)
Table 91. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales by Type (2022-2027) & (Kiloton)
Table 93. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2021) & (Kiloton)
Table 95. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales by Application (2022-2027) & (Kiloton)
Table 97. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2022-2027)
Table 98. India Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Company (2016-2021)
Table 99. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2016-2021)
Table 100. India Nuclear Medicine/Radiopharmaceutic Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Company (2016-2021)
Table 102. India Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2021) & (Kiloton)
Table 103. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2021)
Table 104. India Nuclear Medicine/Radiopharmaceutic Sales by Type (2022-2027) & (Kiloton)
Table 105. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2022-2027)
Table 106. India Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2021) & (Kiloton)
Table 107. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2021)
Table 108. India Nuclear Medicine/Radiopharmaceutic Sales by Application (2022-2027) & (Kiloton)
Table 109. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2022-2027)
Table 110. GE Healthcare Corporation Information
Table 111. GE Healthcare Description and Business Overview
Table 112. GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
Table 113. GE Healthcare Nuclear Medicine/Radiopharmaceutic Product
Table 114. GE Healthcare Recent Development
Table 115. Bracco Imaging Corporation Information
Table 116. Bracco Imaging Description and Business Overview
Table 117. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
Table 118. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product
Table 119. Bracco Imaging Recent Development
Table 120. Mallinckrodt Corporation Information
Table 121. Mallinckrodt Description and Business Overview
Table 122. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
Table 123. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product
Table 124. Mallinckrodt Recent Development
Table 125. Lantheus Medical Imaging Corporation Information
Table 126. Lantheus Medical Imaging Description and Business Overview
Table 127. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
Table 128. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product
Table 129. Lantheus Medical Imaging Recent Development
Table 130. Bayer Corporation Information
Table 131. Bayer Description and Business Overview
Table 132. Bayer Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
Table 133. Bayer Nuclear Medicine/Radiopharmaceutic Product
Table 134. Bayer Recent Development
Table 135. Jubilant Pharma Corporation Information
Table 136. Jubilant Pharma Description and Business Overview
Table 137. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
Table 138. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product
Table 139. Jubilant Pharma Recent Development
Table 140. Nordion Corporation Information
Table 141. Nordion Description and Business Overview
Table 142. Nordion Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
Table 143. Nordion Nuclear Medicine/Radiopharmaceutic Product
Table 144. Nordion Recent Development
Table 145. Eli Lilly Corporation Information
Table 146. Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
Table 147. Eli Lilly Description and Business Overview
Table 148. Eli Lilly Nuclear Medicine/Radiopharmaceutic Product
Table 149. Eli Lilly Recent Development
Table 150. SIEMENS Corporation Information
Table 151. SIEMENS Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
Table 152. SIEMENS Description and Business Overview
Table 153. SIEMENS Nuclear Medicine/Radiopharmaceutic Product
Table 154. SIEMENS Recent Development
Table 155. China Isotope & Radiation Corporation Information
Table 156. China Isotope & Radiation Description and Business Overview
Table 157. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
Table 158. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product
Table 159. China Isotope & Radiation Recent Development
Table 160. Yantai Dongcheng Biochemicals Corporation Information
Table 161. Yantai Dongcheng Biochemicals Description and Business Overview
Table 162. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2016-2021)
Table 163. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product
Table 164. Yantai Dongcheng Biochemicals Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Nuclear Medicine/Radiopharmaceutic Distributors List
Table 168. Nuclear Medicine/Radiopharmaceutic Customers List
Table 169. Nuclear Medicine/Radiopharmaceutic Market Trends
Table 170. Nuclear Medicine/Radiopharmaceutic Market Drivers
Table 171. Nuclear Medicine/Radiopharmaceutic Market Challenges
Table 172. Nuclear Medicine/Radiopharmaceutic Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine/Radiopharmaceutic Product Picture
Figure 2. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2021 & 2027
Figure 3. Tc-99 Product Picture
Figure 4. I-123/131 Product Picture
Figure 5. In-111 Product Picture
Figure 6. Xe-133 Product Picture
Figure 7. Th-201 Product Picture
Figure 8. Ga-67 Product Picture
Figure 9. Other Product Picture
Figure 10. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2021 & 2027
Figure 11. Diagnostic Examples
Figure 12. Therapeutic Examples
Figure 13. Global Nuclear Medicine/Radiopharmaceutic Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2027) & (US$ Million)
Figure 15. Global Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Growth Rate (2016-2027)
Figure 16. Global Nuclear Medicine/Radiopharmaceutic Price Trends Growth Rate (2016-2027) (US$/Ton)
Figure 17. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region: 2016 VS 2021
Figure 18. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region: 2021 VS 2027
Figure 19. North America Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. North America Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) Growth Rate (2016-2027)
Figure 21. Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Europe Nuclear Medicine/Radiopharmaceutic Sales (Million USD) Growth Rate (2016-2027)
Figure 23. China Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. China Nuclear Medicine/Radiopharmaceutic Sales (Million USD) and Growth Rate (2016-2027)
Figure 25. Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. Japan Nuclear Medicine/Radiopharmaceutic Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Growth Rate (2016-2027)
Figure 28. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (Million USD) Growth Rate (2016-2027)
Figure 29. India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Growth Rate (2016-2027)
Figure 30. India Nuclear Medicine/Radiopharmaceutic Sales (Million USD) Growth Rate (2016-2027)
Figure 31. Global 5 Largest Nuclear Medicine/Radiopharmaceutic Players Market Share by Revenue in Nuclear Medicine/Radiopharmaceutic: 2016 & 2020
Figure 32. Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 33. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2016-2021)
Figure 34. Global Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate by Type in 2016 & 2020
Figure 35. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Application (2016-2021)
Figure 36. Global Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2020
Figure 38. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2020
Figure 39. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2020
Figure 40. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2020
Figure 41. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2020
Figure 42. China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2020
Figure 43. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2020
Figure 44. Japan Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2020
Figure 45. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2020
Figure 46. Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2020
Figure 47. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2020
Figure 48. India Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2020
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceutic
Figure 51. Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
Figure 52. Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed